Trade Colgate-Palmolive Co - CL CFD

Add to favourite

86.60

0.25%

0.11

Low: 86.11

High: 86.89

Market Trading Hours* (UTC) Open now
Closes on Friday at 20:00

Mon - Fri: 13:30 - 20:00

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.11

Long position overnight fee

-0.026179%

Short position overnight fee

0.003957%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

Stock exchange

United States of America

Commission on trade

*Information provided by Capital.com

Colgate-Palmolive Co ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats

Prev. Close*	86.65
Open*	86.11
1-Year Change*	14.04%
Day's Range*	86.11 - 86.89
52 wk Range	67.62-82.09
Average Volume (10 days)	4.36M
Average Volume (3 months)	91.77M
Market Cap	66.55B
P/E Ratio	42.27
Shares Outstanding	823.37M
Revenue	19.14B
EPS	1.91
Dividend (Yield %)	2.37536
Beta	0.41
Next Earnings Date	Jan 26, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 18, 2024	86.65	-0.33	-0.38%	86.98	87.25	86.34
Apr 17, 2024	86.70	0.48	0.56%	86.22	86.77	85.86
Apr 16, 2024	86.11	-0.14	-0.16%	86.25	86.68	86.06
Apr 15, 2024	86.10	-0.33	-0.38%	86.43	86.82	86.04
Apr 12, 2024	85.75	0.25	0.29%	85.50	86.19	85.50
Apr 11, 2024	85.91	-0.82	-0.95%	86.73	86.81	85.88
Apr 10, 2024	86.49	-0.69	-0.79%	87.18	87.52	86.32
Apr 9, 2024	87.56	-0.60	-0.68%	88.16	88.17	87.15
Apr 8, 2024	87.68	0.21	0.24%	87.47	87.95	87.45
Apr 5, 2024	87.81	0.57	0.65%	87.24	88.05	86.91
Apr 4, 2024	87.32	-0.98	-1.11%	88.30	88.56	87.23
Apr 3, 2024	88.03	-0.83	-0.93%	88.86	89.03	87.74
Apr 2, 2024	89.05	0.74	0.84%	88.31	89.20	88.31
Apr 1, 2024	88.99	-0.56	-0.63%	89.55	89.72	88.71
Mar 28, 2024	89.96	-0.26	-0.29%	90.22	90.31	89.84
Mar 27, 2024	89.90	0.36	0.40%	89.54	90.22	89.26
Mar 26, 2024	88.85	0.22	0.25%	88.63	89.11	88.24
Mar 25, 2024	88.58	-0.68	-0.76%	89.26	89.32	88.26
Mar 22, 2024	89.14	0.30	0.34%	88.84	89.26	88.77
Mar 21, 2024	88.70	0.57	0.65%	88.13	89.05	87.80

Colgate-Palmolive Co Events

Time (UTC)	Country	Event
Friday, April 26, 2024
Time (UTC) 12:30	Country US	Event Q1 2024 Colgate-Palmolive Co Earnings Call Q1 2024 Colgate-Palmolive Co Earnings Call Forecast - Previous -
Time (UTC) 12:30	Country US	Event Q1 2024 Colgate-Palmolive Co Earnings Release Q1 2024 Colgate-Palmolive Co Earnings Release Forecast - Previous -
Friday, May 10, 2024
Time (UTC) 14:00	Country US	Event Colgate-Palmolive Co Annual Shareholders Meeting Colgate-Palmolive Co Annual Shareholders Meeting Forecast - Previous -
Time (UTC) 14:00	Country US	Event Colgate-Palmolive Co Annual Shareholders Meeting Colgate-Palmolive Co Annual Shareholders Meeting Forecast - Previous -
Friday, July 26, 2024
Time (UTC) 12:30	Country US	Event Q2 2024 Colgate-Palmolive Co Earnings Release Q2 2024 Colgate-Palmolive Co Earnings Release Forecast - Previous -

View all events

Annual
Quarterly

	2022	2021	2020	2019	2018
Total revenue	17967	17421	16471	15693	15544
Revenue	17967	17421	16471	15693	15544
Cost of Revenue, Total	7719	7046	6454	6360	6282
Gross Profit	10248	10375	10017	9333	9262
Total Operating Expense	15089	14089	12586	12146	11859
Selling/General/Admin. Expenses, Total	6560	6407	6019	5515	5356
Depreciation / Amortization	80	89	88	62	59
Interest Expense (Income) - Net Operating	-12	-12	-12	-9	-10
Unusual Expense (Income)	803	555	-11	174	161
Other Operating Expenses, Total	-61	4	48	44	11
Operating Income	2878	3332	3885	3547	3685
Interest Income (Expense), Net Non-Operating	-153	-175	-164	-145	-143
Other, Net	-65	-70	-74	-101	-78
Net Income Before Taxes	2660	3087	3647	3301	3464
Net Income After Taxes	1967	2338	2860	2527	2638
Minority Interest	-182	-172	-165	-160	-158
Net Income Before Extra. Items	1785	2166	2695	2367	2480
Net Income	1785	2166	2695	2367	2400
Income Available to Common Excl. Extra. Items	1785	2166	2695	2367	2480
Income Available to Common Incl. Extra. Items	1785	2166	2695	2367	2400
Diluted Net Income	1785	2166	2695	2367	2400
Diluted Weighted Average Shares	838.8	848.3	859.3	861.1	873
Diluted EPS Excluding Extraordinary Items	2.12804	2.55334	3.13627	2.74881	2.84078
Dividends per Share - Common Stock Primary Issue	1.86	1.79	1.75	1.71	1.66
Diluted Normalized EPS	2.83595	3.11581	3.1527	2.9035	2.98122
Total Extraordinary Items					-80

	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Total revenue	4915	4822	4770	4629	4455
Revenue	4915	4822	4770	4629	4455
Cost of Revenue, Total	2038	2035	2058	2055	1907
Gross Profit	2877	2787	2712	2574	2548
Total Operating Expense	3886	3851	4129	4429	3507
Selling/General/Admin. Expenses, Total	1822	1766	1758	1632	1633
Other Operating Expenses, Total	25	29	15	1	-5
Operating Income	1029	971	641	200	948
Interest Income (Expense), Net Non-Operating	-58	-58	-54	-55	-40
Other, Net	-15	-26	-26	-13	-16
Net Income Before Taxes	956	887	561	132	892
Net Income After Taxes	747	534	414	43	682
Minority Interest	-39	-32	-42	-38	-64
Net Income Before Extra. Items	708	502	372	5	618
Net Income	708	502	372	5	618
Income Available to Common Excl. Extra. Items	708	502	372	5	618
Income Available to Common Incl. Extra. Items	708	502	372	5	618
Diluted Net Income	708	502	372	5	618
Diluted Weighted Average Shares	827.3	831.3	833	834	838.5
Diluted EPS Excluding Extraordinary Items	0.8558	0.60387	0.44658	0.006	0.73703
Dividends per Share - Common Stock Primary Issue	0.48	0.48	0.47	0.47	0.47
Diluted Normalized EPS	0.857	0.77589	0.72989	0.58351	0.7115
Unusual Expense (Income)	1	21	298	741	-28

Annual
Quarterly

	2022	2021	2020	2019	2018
Total Current Assets	5113	4397	4338	4179	3793
Cash and Short Term Investments	950	866	925	906	736
Cash & Equivalents	775	832	888	883	726
Short Term Investments	175	34	37	23	10
Total Receivables, Net	1504	1297	1264	1440	1400
Accounts Receivable - Trade, Net	1504	1297	1264	1440	1400
Total Inventory	2074	1692	1673	1400	1250
Other Current Assets, Total	585	542	476	433	407
Total Assets	15731	15040	15920	15034	12161
Property/Plant/Equipment, Total - Net	4785	4257	4237	3750	3881
Property/Plant/Equipment, Total - Gross	10061	9426	9272	8580	8336
Accumulated Depreciation, Total	-5276	-5169	-5035	-4830	-4455
Goodwill, Net	3352	3284	3824	3508	2530
Intangibles, Net	1920	2462	2894	2667	1637
Long Term Investments	70	64	56	50	46
Other Long Term Assets, Total	491	576	571	880	274
Total Current Liabilities	4004	4051	4404	4038	3341
Accounts Payable	1551	1479	1393	1237	1222
Accrued Expenses	2096	2079	2248	1886	1687
Notes Payable/Short Term Debt	11	39	258	260	12
Current Port. of LT Debt/Capital Leases	14	12	9	254	0
Other Current Liabilities, Total	332	442	496	401	420
Total Liabilities	15330	14431	15177	14917	12263
Total Long Term Debt	8741	7194	7334	7333	6354
Long Term Debt	8741	7194	7334	7333	6354
Deferred Income Tax	383	395	426	507	235
Minority Interest	405	362	358	441	299
Other Liabilities, Total	1797	2429	2655	2598	2034
Total Equity	401	609	743	117	-102
Common Stock	1466	1466	1466	1466	1466
Additional Paid-In Capital	3546	3269	2969	2488	2204
Retained Earnings (Accumulated Deficit)	24573	24350	23699	22501	21615
Treasury Stock - Common	-25128	-24089	-23045	-22063	-21196
Other Equity, Total	-4056	-4387	-4346	-4275	-4191
Total Liabilities & Shareholders’ Equity	15731	15040	15920	15034	12161
Total Common Shares Outstanding	830.213	840.48	849.894	854.702	862.913

	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Total Current Assets	5357	5437	5466	5113	5278
Cash and Short Term Investments	1198	1086	1143	950	1146
Cash & Equivalents	951	819	867	775	938
Short Term Investments	247	267	276	175	208
Total Receivables, Net	1577	1656	1590	1504	1425
Accounts Receivable - Trade, Net	1577	1656	1590	1504	1425
Total Inventory	1931	2039	2110	2074	2073
Other Current Assets, Total	651	656	623	585	634
Total Assets	16043	16227	16173	15731	16288
Property/Plant/Equipment, Total - Net	4409	4431	4363	4307	4123
Property/Plant/Equipment, Total - Gross	9979	9988	9815	9583	9318
Accumulated Depreciation, Total	-5570	-5557	-5452	-5276	-5195
Goodwill, Net	3327	3373	3375	3352	3538
Intangibles, Net	1861	1901	1918	1920	2219
Other Long Term Assets, Total	1089	1085	1051	969	1130
Total Current Liabilities	4602	4632	4441	4004	4492
Accounts Payable	1482	1544	1609	1551	1541
Accrued Expenses	2732	2600	2498	2096	2489
Notes Payable/Short Term Debt	18	19	22	11	16
Current Port. of LT Debt/Capital Leases	16	16	15	14	13
Other Current Liabilities, Total	354	453	297	332	433
Total Liabilities	16052	16291	16179	15330	15666
Total Long Term Debt	8690	8954	8870	8741	8219
Long Term Debt	8690	8954	8870	8741	8219
Deferred Income Tax	430	363	421	383	551
Minority Interest	415	379	431	405	431
Other Liabilities, Total	1915	1963	2016	1797	1973
Total Equity	-9	-64	-6	401	622
Common Stock	1466	1466	1466	1466	1466
Additional Paid-In Capital	3762	3688	3603	3546	3518
Retained Earnings (Accumulated Deficit)	24571	24258	24153	24573	24566
Treasury Stock - Common	-25834	-25541	-25245	-25128	-24749
Other Equity, Total	-3974	-3935	-3983	-4056	-4179
Total Liabilities & Shareholders’ Equity	16043	16227	16173	15731	16288
Total Common Shares Outstanding	823.372	826.692	829.568	830.213	835.214
Long Term Investments				70

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	1967	2338	2860	2527	2558
Cash From Operating Activities	2556	3325	3719	3133	3056
Cash From Operating Activities	545	556	539	519	511
Deferred Taxes	-78	-132	-120	17	27
Non-Cash Items	848	760	59	5	115
Cash Taxes Paid	945	890	845	803	847
Cash Interest Paid	151	194	188	185	194
Changes in Working Capital	-726	-197	381	65	-155
Cash From Investing Activities	-1601	-592	-779	-2099	-1170
Capital Expenditures	-696	-567	-410	-335	-436
Other Investing Cash Flow Items, Total	-905	-25	-369	-1764	-734
Cash From Financing Activities	-952	-2774	-2919	-870	-2679
Total Cash Dividends Paid	-1691	-1679	-1654	-1614	-1591
Issuance (Retirement) of Stock, Net	-890	-896	-602	-704	-909
Issuance (Retirement) of Debt, Net	1647	-175	-564	1448	-179
Foreign Exchange Effects	-60	-15	-16	-7	-16
Net Change in Cash	-57	-56	5	157	-809
Financing Cash Flow Items	-18	-24	-99

	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Net income/Starting Line	414	1967	1924	1242	603
Cash From Operating Activities	735	2556	1883	914	386
Cash From Operating Activities	128	545	410	276	138
Deferred Taxes	-20	-78	-13	-16	-7
Non-Cash Items	274	848	191	118	110
Cash Taxes Paid	171	945	690	477	155
Changes in Working Capital	-61	-726	-629	-706	-458
Cash From Investing Activities	-264	-1601	-1428	-482	-141
Capital Expenditures	-163	-696	-475	-300	-122
Other Investing Cash Flow Items, Total	-101	-905	-953	-182	-19
Cash From Financing Activities	-375	-952	-286	-385	-204
Financing Cash Flow Items	5	-18	-38	-18	-5
Total Cash Dividends Paid	-390	-1691	-1206	-814	-378
Issuance (Retirement) of Stock, Net	-58	-890	-497	-555	-239
Issuance (Retirement) of Debt, Net	68	1647	1455	1002	418
Foreign Exchange Effects	-4	-60	-63	-21	4
Net Change in Cash	92	-57	106	26	45

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Colgate-Palmolive Company profile

About Colgate-Palmolive Company

Colgate-Palmolive Company (Colgate) is a household and consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company is also engaged in various product categories of the personal care market with operations in liquid hand soap, which it sells under the Palmolive, Protex and Softsoap brands. Its Personal Care products also include bar soaps, shower gels, deodorants, antiperspirants, and shampoos and conditioners. Colgate manufactures and markets a range of products for the home care market, including Ajax, Axion and Palmolive dishwashing liquids and Ajax, Fabuloso and Murphy household cleaners. The Company, through its Hill's Pet Nutrition segment (Hill's), manufactures pet nutrition products for dogs and cats.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Colgate-Palmolive Company revenues increased 6% to $17.42B. Net income decreased 20% to $2.17B. Revenues reflect Oral, Personal and Home Care segment increase of 4% to $14.11B, Pet Nutrition segment increase of 15% to $3.31B, Latin America segment increase of 7% to $3.66B, Asia Pacific segment increase of 6% to $2.87B, Europe segment increase of 3% to $2.84B.

Equity composition

Common Stock $1 Par, 03/11, 2B auth., 488,893,996 outstanding, net of treasury @ cost of $11.81B. Insiders own approx. .29%. PO:3/73, 1.1M shs @ $90.50 by Goldman Sachs. 05/2013, 2-for-1 Stock split.

Industry:

Personal Products (NEC)

300 Park Ave
NEW YORK
NEW YORK 10022
US

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024